GABAPENTIN
NDC 25000-104, GABAPENTIN, capsule, from MARKSANS PHARMA LIMITED.
- Product NDC
- 25000-104
- Status
- Listed
- Labeler
- MARKSANS PHARMA LIMITED
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA090007
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/25000-104 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GABAPENTIN300 mg/1
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 25000-104-03 | 25000010403 | 30 CAPSULE in 1 BOTTLE (25000-104-03) |
| 25000-104-12 | 25000010412 | 500 CAPSULE in 1 BOTTLE (25000-104-12) |
| 25000-104-14 | 25000010414 | 1000 CAPSULE in 1 BOTTLE (25000-104-14) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/98bb408d-c402-4da6-8f9d-5de4833dedc4
Use it
Look up 25000-104 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/25000-104 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 25000-104. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.